Pretreatment with the FAK inhibitor PF573228 (10 μM) or JNK inhibitor SP600125 (30 μM) suppressed the PDA-induced upregulation of these genes, indicating that their expression is dependent on FAK–JNK signaling activation (Figure 11A–C). The gene discussed is PTK2; the disease is Patent ductus arteriosus.